Elevated levels of microtubule destabilizing factors in a Taxol-resistant/dependent A549 cell line with an α-tubulin mutation

Cancer Research

Volumn 63, Issue 6, 2003, Pages 1207-1213

  Martello, Laura A ^a,b   Verdier Pinard, Pascal ^a   Shen, Heng Jia ^a   He, Lifeng ^a   Torres, Keila ^a   Orr, George A ^a   Horwitz, Susan Band ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; BETA TUBULIN; MICROTUBULE ASSOCIATED PROTEIN 4; PACLITAXEL; STATHMIN;

AMINO ACID SEQUENCE; ARTICLE; CELL LINE; CONTROLLED STUDY; HETEROZYGOSITY; HUMAN; HUMAN CELL; ISOELECTRIC FOCUSING; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; PROTEIN POLYMERIZATION; PROTEIN PROTEIN INTERACTION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

AMINO ACID SEQUENCE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, NEOPLASM; HUMANS; MICROTUBULE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; MOLECULAR SEQUENCE DATA; PACLITAXEL; PHOSPHOPROTEINS; POINT MUTATION; PROTEIN CONFORMATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATHMIN; TUBULIN; TUMOR CELLS, CULTURED;

EID: 0037444386     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Gottesman, M. M., and Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 62: 385-427, 1993.
2. Giannakakou, P., Sackett, D. L., Kang, Y. K., Zhan, Z., Buters, J. T., Fojo, T., and Poruchynsky, M. S. Paclitaxel-resistant human ovarian cancer cells have mutant β-tubulins that exhibit impaired paclitaxel-driven polymerization. J. Biol. Chem., 272: 17118-17125, 1997.
3. Gonzalez-Garay, M. L., Chang, L., Blade, K., Menick, D. R., and Cabral, F. A β-tubulin leucine cluster involved in microtubule assembly and paclitaxel resistance. J. Biol. Chem., 274: 23875-23882, 1999.
4. He, L., Yang, C-P. H., and Horwitz, S. B. Mutations in β-tubulin map to domains involved in regulation of microtubule stability in epothilone-resistant cell lines. Mol. Cancer Ther., 1: 3-10, 2001.
5. Jaffrezou, J. P., Dumontet, C., Derry, W. B., Duran, G., Chen, G., Tsuchiya, E., Wilson, L., Jordan, M. A., and Sikic, B. I. Novel mechanism of resistance to paclitaxel (Taxol) in human K562 leukemia cells by combined selection with PSC 833. Oncol. Res., 7: 517-527, 1995.
6. Haber, M., Burkhart, C. A., Regl, D. L., Madafiglio, J., Norris, M. D., and Horwitz, S. B. Altered expression of Mβ2, the class II β-tubulin isotype, in a murine J774.2 cell line with a high level of taxol resistance. J. Biol. Chem., 270: 31269-31275, 1995.
7. Dumontet, C., Duran, G. E., Steger, K. A., Beketic-Oreskovic, L., and Sikic, B. I. Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol). Cancer Res., 56: 1091-1097, 1996.
8. Kavallaris, M., Kuo, D. Y., Burkhart, C. A., Regl, D. L., Norris, M. D., Haber, M., and Horwitz, S. B. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific β-tubulin isotypes. J. Clin. Investig., 100: 1282-1293, 1997.
9. Ranganathan, S., Benetatos, C. A., Colarusso, P. J., Dexter, D. W., and Hudes, G. R. Altered β-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells. Br. J. Cancer, 77: 562-566, 1998.
10. Martello, L. A., McDaid, H. M., Regl, D. L., Yang, C. P., Meng, D., Pettus, T. R., Kaufman, M. D., Arimoto, H., Danishefsky, S. J., Smith, A. B., III, and Horwitz, S. B. Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines. Clin. Cancer Res., 6: 1978-1987, 2000.
11. Goncalves, A., Braguer, D., Kamath, K., Martello, L., Briand, C., Horwitz, S., Wilson, L., and Jordan, M. A. Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics. Proc. Natl. Acad. Sci. USA, 98: 11737-11742, 2001.
12. Kavallaris, M., Burkhart, C. A., and Horwitz, S. B. Antisense oligonucleotides to class III β-tubulin sensitize drug-resistant cells to Taxol. Br. J. Cancer, 80: 1020-1025, 1999.
13. Panda, D., Miller, H. P., Banerjee, A., Ludueña, R. F., and Wilson, L. Microtubule dynamics in vitro are regulated by the tubulin isotype composition. Proc. Natl. Acad. Sci. USA, 91: 11358-11362, 1994.
14. Banerjee, A., Roach, M. C., Trcka, P., and Ludueña, R. F. Increased microtubule assembly in bovine brain tubulin lacking the type III isotype of β-tubulin. J. Biol. Chem., 265: 1794-1799, 1990.
15. Lu, Q., and Ludueña, R. F. Removal of βIII isotype enhances taxol induced microtubule assembly. Cell Struct. Funct., 18: 173-182, 1993.
16. Derry, W. B., Wilson, L., Khan, I. A., Ludueña, R. F., and Jordan, M. A. Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified β-tubulin isotypes. Biochemistry. 36: 3554-3562, 1997.
17. Kavallaris, M., Tait, A. S., Walsh, B. J., He, L., Horwitz, S. B., Norris, M. D., and Haber, M. Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells. Cancer Res., 61: 5803-5809, 2001.
18. Vallee, R. B. A taxol-dependent procedure for the isolation of microtubules and microtubule-associated proteins (MAPs). J. Cell Biol., 92: 435-442, 1982.
19. Patestos, N. P., Fauth, M., and Radola, B. J. Fast and sensitive protein staining with colloidal acid violet 17 following isoelectric focusing in carrier ampholyte generated and immobilized pH gradients. Electrophoresis, 9: 488-496, 1988.
20. Brattsand, G., Friedrich, B., and Gullberg, M. A rapid separation procedure to analyse phosphorylation of two putative protein kinase C substrates in intact lymphocytes. Scand. J. Immunol., 30: 233-240, 1989.
21. Nogales, E., Wolf, S. G., and Downing, K. H. Structure of the αβ tubulin dimer by electron crystallography. Nature (Lond.), 391: 199-203, 1998.
22. Rao, S., Aberg, F., Nieves, E., Horwitz, S. B., and Orr, G. A. Identification by mass spectrometry of a new α-tubulin isotype expressed in human breast and lung carcinoma cell lines. Biochemistry, 40: 2096-2103, 2001.
23. Marklund, U., Larsson, N., Gradin, H. M., Brattsand, G., and Gullberg, M. Oncoprotein 18 is a phosphorylation-responsive regulator of microtubule dynamics. EMBO J. 15: 5290-5298, 1996.
24. Horwitz, S. B., Shen, H. J., He, L., Dittmar, P., Neef, R., Chen, J., and Schubart, U. K. The microtubule-destabilizing activity of metablastin (p19) is controlled by phosphorylation. J. Biol. Chem., 272: 8129-8132, 1997.
25. Drewes, G., Ebneth, A., and Mandelkow, E. M. MAPs. MARKs and microtubule dynamics. Trends Biochem. Sci., 23: 307-311, 1998.
26. Chang, W., Gruber, D., Chari, S., Kitazawa, H., Hamazumi, Y., Hisanaga, S., and Bulinski, J. C. Phosphorylation of MAP4 affects microtubule properties and cell cycle progression. J. Cell Sci., 114: 2879-2887, 2001.
27. Cabral, F., Abraham, I., and Gottesman, M. M. Isolation of a taxol-resistant Chinese hamster ovary cell mutant that has an alteration in α-tubulin. Proc. Natl. Acad. Sci. USA, 78: 4388-4391, 1981.
28. Schibler, M. J., and Cabral, F. Taxol-dependent mutants of Chinese hamster ovary cells with alterations in α- and β-tubulin. J. Cell Biol., 102: 1522-1531, 1986.
29. James, S. W., Silflow, C. D., Stroom, P., and Lefebvre, P. A. A mutation in the α1-tubulin gene of Chlamydomonas reinhardtii confers resistance to anti-microtubule herbicides. J. Cell Sci., 106: 209-218, 1993.
30. Yamamoto, E., Zeng, L., and Baird, W. V. α-Tubulin missense mutations correlate with antimicrotubule drug resistance in Eleusine indica. Plant Cell, 10: 297-308, 1998.
31. Anthony, R. G., Waldin, T. R., Ray, J. A., Bright, S. W., and Hussey, P. J. Herbicide resistance caused by spontaneous mutation of the cytoskeletal protein tubulin. Nature (Lond.), 393: 260-263, 1998.
32. Poruchynsky, M. S., Annable, T., Kim, J., Fojo, T., Loganzo, F., and Greenberger, L. Tumor cells resistant to tubulin-depolymerizing hemiasterlin analog, WAY-174286, display different resistance mechanisms, including mutations in α- or β-tubulin. Clin. Cancer Res., 7(Suppl.): 3810S, 2001.
33. Richards, K. L., Anders, K. R., Nogales, E., Schwartz, K., Downing, K. H., and Botstein, D. Structure-function relationships in yeast tubulins. Mol. Biol. Cell, 11: 1887-1903, 2000.
34. Muller, D. R., Schindler, P., Towbin, H., Wirth, U., Voshol, H., Hoving, S., and Steinmetz, M. O. Isotope-tagged cross-linking reagents. A new tool in mass spectrometric protein interaction analysis. Anal. Chem., 73: 1927-1934, 2001.
35. Wallon, G., Rappsilber, J., Mann, M., and Serrano, L. Model for stathmin/OP18 binding to tubulin. EMBO J., 19: 213-222, 2000.
36. Curmi, P. A., Nogues, C., Lachkar, S., Carelle, N., Gonthier, M. P., Sobel, A., Lidereau, R., and Bieche, I. Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours. Br. J. Cancer, 82: 142-150, 2000.
37. Jourdain, L., Curmi, P., Sobel, A., Pantaloni, D., and Carlier, M. F. Stathmin: a tubulin-sequestering protein which forms a ternary T2S complex with two tubulin molecules. Biochemistry, 36: 10817-10821, 1997.
38. Larsson, N., Melander, H., Marklund, U., Osterman, O., and Gullberg, M. G2/M transition requires multisite phosphorylation of oncoprotein 18 by two distinct protein kinase systems. J. Biol. Chem., 270: 14175-14183, 1995.
39. Bulinski, J. C. MAP4. In: J. S. Hyams and C. W. Lloyd (eds.), Microtubules, pp. 167-182. New York: Wiley-Liss, Inc., 1994.
40. Ookata, K., Hisanaga, S., Sugita, M., Okuyama, A., Murofushi, H., Kitazawa, H., Chari, S., Bulinski, J. C., and Kishimoto, T. MAP4 is the in vivo substrate for CDC2 kinase in HeLa cells: identification of an M-phase specific and a cell cycle-independent phosphorylation site in MAP4. Biochemistry, 36: 15873-15883, 1997.
41. Mori, A., Aizawa, H., Saido, T. C., Kawasaki, H., Mizuno, K., Murofushi, H., Suzuki, K., and Sakai, H. Site-specific phosphorylation by protein kinase C inhibits assembly-promoting activity of microtubule-associated protein 4. Biochemistry, 30: 9341-9346, 1991.
42. Ebneth, A., Drewes, G., and Mandelkow, E. Phosphorylation of MAP2c and MAP4 by MARK kinases leads to the destabilization of microtubules in cells. Cell Motil. Cytoskelet., 44: 209-224, 1999.
43. Ookata, K., Hisanaga, S., Bulinski, J. C., Murofushi, H., Aizawa, H., Itoh, T. J., Hotani, H., Okumura, E., Tachibana, K., and Kishimoto, T. Cyclin B interaction with microtubule-associated protein 4 (MAP4) targets p34cdc2 kinase to microtubules and is a potential regulator of M-phase microtubule dynamics. J. Cell Biol., 128: 849-862, 1995.
44. Kuntziger, T., Gavet, O., Manceau, V., Sobel, A., and Bornens, M. Stathmin/Op18 phosphorylation is regulated by microtubule assembly. Mol. Biol. Cell, 12: 437-448, 2001.
45. Sontag, E., Nunbhakdi-Craig, V., Lee, G., Brandt, R., Kamibayashi, C., Kuret, J., White, C. L., III, Mumby, M. C., and Bloom, G. S. Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies. J. Biol. Chem., 274: 25490-25498, 1999.
46. Sontag, E., Nunbhakdi-Craig, V., Lee, G., Bloom, G. S., and Mumby, M. C. Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A. Neuron, 17: 1201-1207, 1996.
47. Ahn, J., Murphy, M., Kratowicz, S., Wang, A., Levine, A. J., and George, D. L. Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction. Oncogene, 18: 5954-5958, 1999.
48. Johnsen, J. I., Aurelio, O. N., Kwaja, Z., Jorgensen, G. E., Pellegata, N. S., Plattner, R., Stanbridge, E. J., and Cajot, J. F. p53-mediated negative regulation of stathmin/Op18 expression is associated with G(2)/M cell-cycle arrest. Int. J. Cancer, 88: 685-691, 2000.
49. Murphy, M., Hinman, A., and Levine, A. J. Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes Dev., 10: 2971-2980, 1996.
50. Zhang, C. C., Yang, J. M., Bash-Babula, J., White, E., Murphy, M., Levine, A. J., and Hait, W. N. DNA damage increases sensitivity to vinca alkaloids and decreases sensitivity to taxanes through p53-dependent repression of microtubule-associated protein 4. Cancer Res., 59: 3663-3670, 1999.
51. Zhang, C. C., Yang, J. M., White, E., Murphy, M., Levine, A., and Hait, W. N. The role of MAP4 expression in the sensitivity to paclitaxel and resistance to vinca alkaloids in p53 mutant cells. Oncogene, 16: 1617-1624, 1998.
52. Bash-Babula, J., Toppmeyer, D., Labassi, M., Reidy, J., Orlick, M., Senzon, R., Alli, E., Kearney, T., August, D., Shih, W., Yang, J. M., and Hait, W. N. A Phase I/pilot study of sequential doxorubicin/vinorelbine: effects on p53 and microtubule-associated protein 4. Clin. Cancer Res., 8: 1057-1064, 2002.